Topics

Roche's Tecentriq gains first approval in China as treatment for extensive-stage small-cell lung cancer https://www.firstwordpharma.com/node/1700775  $RHHBY

05:51 EST 14 Feb 2020 | FirstWord Pharma

Roche's Tecentriq gains first approval in China as treatment for extensive-stage small-cell lung cancer https://www.firstwordpharma.com/node/1700775 

Original Article: Roche's Tecentriq gains first approval in China as treatment for extensive-stage small-cell lung cancer https://www.firstwordpharma.com/node/1700775  $RHHBY

NEXT ARTICLE

More From BioPortfolio on "Roche's Tecentriq gains first approval in China as treatment for extensive-stage small-cell lung cancer https://www.firstwordpharma.com/node/1700775  $RHHBY"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...